Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
1(6%)
Results Posted
92%(12 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
3
19%
Ph not_applicable
4
25%
Ph phase_2
2
13%
Ph phase_3
6
38%
Ph early_phase_1
1
6%

Phase Distribution

1

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 2Efficacy & side effects
2(12.5%)
Phase 3Large-scale testing
6(37.5%)
Phase 4Post-market surveillance
3(18.8%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(13)
Terminated(2)

Detailed Status

Completed13
Withdrawn1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.3%)
Phase 22 (12.5%)
Phase 36 (37.5%)
Phase 43 (18.8%)
N/A4 (25.0%)

Trials by Status

withdrawn16%
terminated16%
active_not_recruiting16%
completed1381%

Recent Activity

1 active trials
Showing 5 of 16
active_not_recruitingnot_applicable

Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study

NCT05763771
completednot_applicable

Reducing Cancer Disparities Among Latinos in Texas

NCT01504919
completedphase_4

Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers

NCT02245308
completedphase_3

Providing Free Nicotine Patches to Quitline Smokers

NCT01736085
completedphase_3

Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging

NCT01287377
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT05763771Not Applicable

Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study

Active Not Recruiting
NCT01504919Not Applicable

Reducing Cancer Disparities Among Latinos in Texas

Completed
NCT02245308Phase 4

Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers

Completed
NCT01736085Phase 3

Providing Free Nicotine Patches to Quitline Smokers

Completed
NCT01287377Phase 3

Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging

Completed
NCT01502306Phase 3

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

Completed
NCT01289275Phase 4

Smoking Cessation in Hospitalized Smokers

Completed
NCT02942212Early Phase 1

Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II

Withdrawn
NCT01040260Not Applicable

Low-Cost Contingency Management for Smoking Cessation

Completed
NCT01406223Phase 3

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation

Completed
NCT01806779Phase 2

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers

Completed
NCT00534404Not Applicable

A Randomized Trial of Internet Access to Nicotine Patches

Completed
NCT01560507Phase 2

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Terminated
NCT01303861Phase 3

Concurrent Bupropion / Varenicline for Smoking Cessation

Completed
NCT01538394Phase 4

Clinical Trial to Evaluate the Efficacy of Smoking Cessation

Completed
NCT00894166Phase 3

Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype

Completed

All 16 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
16